Valeant Pharmaceuticals International (NYSE: VRX) and GlaxoSmithKline (NYSE: GSK) entered into an exclusive worldwide collaboration agreement for the investigational drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE